Compare WVE & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | IE |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | Singapore | United States |
| Employees | 317 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.1B |
| IPO Year | 2015 | 2022 |
| Metric | WVE | IE |
|---|---|---|
| Price | $5.68 | $10.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 3 |
| Target Price | ★ $29.81 | $18.17 |
| AVG Volume (30 Days) | ★ 3.9M | 1.8M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,704,000.00 | $3,244,000.00 |
| Revenue This Year | N/A | $44.79 |
| Revenue Next Year | $85.67 | $16.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 149.43 | 11.82 |
| 52 Week Low | $5.02 | $7.72 |
| 52 Week High | $21.73 | $21.55 |
| Indicator | WVE | IE |
|---|---|---|
| Relative Strength Index (RSI) | 35.24 | 33.33 |
| Support Level | $5.02 | $8.53 |
| Resistance Level | $7.65 | $15.70 |
| Average True Range (ATR) | 0.32 | 0.90 |
| MACD | 0.00 | -0.31 |
| Stochastic Oscillator | 10.14 | 2.29 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.